Summary
A 46-year-old program engineer was denied a security clearance due to concerns under Guideline E (Personal Conduct) and Guideline H (Drug Involvement). The denial stemmed from his admitted marijuana use between January 2016 and October 2022, which occurred while he held a sensitive position and had access to classified information.
Further issues arose from his failure to disclose this drug use on his security clearance application. The applicant provided inconsistent statements regarding this omission, leading to allegations that he failed to provide truthful and candid answers during the clearance process, thereby raising questions about his reliability and trustworthiness.
The judge determined that the applicant's admitted marijuana use while in a sensitive role, coupled with his lack of candor on the application and expressed intent to continue using marijuana, provided insufficient evidence to mitigate concerns about his reliability and trustworthiness. Consequently, eligibility for access to classified information was denied.
Why the Applicant Was Denied
- The applicant admitted to using marijuana while holding a sensitive position.
- The applicant failed to disclose his marijuana use on his security clearance application, raising questions about his honesty and reliability.
- The applicant expressed intent to continue using marijuana, which undermined his credibility regarding future compliance with laws and regulations.
Conditions Referenced
- AG ¶ 25(a)appliedSubstance Misuse
- AG ¶ 25(c)appliedIllegal Possession of a Controlled Substance
- AG ¶ 25(f)appliedIllegal Drug Use While Holding a Sensitive Position
- AG ¶ 25(g)appliedIntent to Continue Drug Involvement
- AG ¶ 16(a)appliedDeliberate Omission or Falsification
Key Rule Quoted
“Eligibility for a security clearance is predicated upon the applicant meeting the criteria contained in the adjudicative guidelines.”
Procedural Posture
- SOR issuedNov 17, 2022
- Answer filed—
- Hearing heldDec 7, 2023
- Decision dateMar 4, 2024
Cite For
- Denial of Security Clearance Due to Drug Involvement Under Guideline H
- Failure to Disclose Drug Use on Security Clearance Application Under Guideline E
- Insufficient Evidence to Mitigate Security Concerns Regarding Reliability and Trustworthiness.